Loading
This study tests a PARP inhibitor; the registry reports that it is recruiting.
The registry lists NCT06713369 as recruiting, last updated 2026-06-24. Enrolment is 8 planned participants, an estimate. Interventions: Saruparib (AZD5305), [14C]-AZD5305 microtracer, [14C]-AZD5305 (therapeutic dose). Primary measures include Absolute bioavailability (F) of Saruparib; Total radioactivity recovery in urine and faeces. No results are posted in the registry; this does not exclude separate publications.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/